Foundation Fighting Blindness Retinal Degeneration Fund
See Remarks at Opus Genetics, Inc. (IRD)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $18.8M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 2SEC | IRDOpus Genetics, Inc. | Sell | 556,0003,236,171 held (−15%) | $4.96 | $2.8M | -22.5% |
| May 20SEC | IRDOpus Genetics, Inc. | Sell | 1,700,0003,792,171 held (−31%) | $4.35 | $7.4M | -11.7% |
| Dec 11SEC | IRDOpus Genetics, Inc. | Sell | 4,000,0005,492,171 held (−42%) | $2.15 | $8.6M | +78.6% |
- Sell
See Remarks Foundation Fighting Blindness Retinal Degeneration Fund sold $7.4M of IRD at $4.35 — cuts the stake by 31%.
- Sell
See Remarks Foundation Fighting Blindness Retinal Degeneration Fund sold $8.6M of IRD at $2.15 — cuts the stake by 42%.